{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:58:11Z","timestamp":1791655091957,"version":"4.3.4"},"reference-count":85,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"BMBF","award":["FK0316180C"],"award-info":[{"award-number":["FK0316180C"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB740HE3763\/15"],"award-info":[{"award-number":["SFB740HE3763\/15"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1007601","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T17:27:56Z","timestamp":1552930076000},"page":"e1007601","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals"],"prefix":"10.1371","volume":"15","author":[{"given":"Markus","family":"Lesch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madlen","family":"Luckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friderike","family":"Weege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Gravenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Raftery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sieben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Martin-Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Imai-Matsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert-William","family":"Welke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Frise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther","family":"Sch\u00f6nrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2187-2057","authenticated-orcid":true,"given":"Alexander","family":"Karlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"ref1","unstructured":"WHO. Influenza (Seasonal), Fact sheet N\u00b0211. 2014."},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cell.2009.01.029","article-title":"The influenza virus enigma","volume":"136","author":"R Salomon","year":"2009","journal-title":"Cell"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/infdis\/jiq012","article-title":"Emerging influenza antiviral resistance threats","volume":"203","author":"FG Hayden","year":"2011","journal-title":"J Infect Dis"},{"issue":"20","key":"ref4","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1128\/JVI.01200-09","article-title":"Zanamivir-resistant influenza viruses with a novel neuraminidase mutation","volume":"83","author":"AC Hurt","year":"2009","journal-title":"J Virol"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nrmicro2613","article-title":"Influenza A viruses: new research developments","volume":"9","author":"RA Medina","year":"2011","journal-title":"Nature reviews Microbiology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2015.00277","article-title":"Maraviroc\u2014A CCR5 Antagonist for the Treatment of HIV-1 Infection","volume":"6","author":"E Van Der Ryst","year":"2015","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/ncomms1158","article-title":"Differential use of importin-alpha isoforms governs cell tropism and host adaptation of influenza virus","volume":"2","author":"G Gabriel","year":"2011","journal-title":"Nat Commun"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"e1002488","DOI":"10.1371\/journal.ppat.1002488","article-title":"Human-like PB2 627K influenza virus polymerase activity is regulated by importin-alpha1 and -alpha7","volume":"8","author":"B Hudjetz","year":"2012","journal-title":"PLoS Pathog"},{"issue":"18","key":"ref9","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"HL Janssen","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1128\/AAC.04220-14","article-title":"In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122","volume":"59","author":"S Ottosen","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"7282","key":"ref11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature08760","article-title":"Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication","volume":"463","author":"A Karlas","year":"2010","journal-title":"Nature"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.chom.2010.05.008","article-title":"Cellular networks involved in the influenza virus life cycle","volume":"7","author":"T Watanabe","year":"2010","journal-title":"Cell Host Microbe"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.celrep.2018.03.045","article-title":"Genome-wide CRISPR\/Cas9 Screen Identifies Host Factors Essential for Influenza Virus Replication","volume":"23","author":"J Han","year":"2018","journal-title":"Cell reports"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"TT Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ijc.25864","article-title":"Regorafenib (BAY 73\u20134506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity","volume":"129","author":"SM Wilhelm","year":"2011","journal-title":"Int J Cancer"},{"issue":"25","key":"ref16","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.2174\/1381612023393053","article-title":"BAY 43\u20139006: early clinical data in patients with advanced solid malignancies","volume":"8","author":"SJ Hotte","year":"2002","journal-title":"Curr Pharm Des"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/rmv.703","article-title":"The host interactome of influenza virus presents new potential targets for antiviral drugs","volume":"21","author":"ML Shaw","year":"2011","journal-title":"Rev Med Virol"},{"issue":"20","key":"ref18","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1093\/bioinformatics\/btr474","article-title":"cSSMD: assessing collective activity for addressing off-target effects in genome-scale RNA interference screens","volume":"27","author":"XD Zhang","year":"2011","journal-title":"Bioinformatics"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"W Huang da","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"D1049","DOI":"10.1093\/nar\/gku1179","article-title":"Gene Ontology Consortium. Gene Ontology Consortium: going forward","volume":"43","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"M Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"D691","DOI":"10.1093\/nar\/gkq1018","article-title":"Reactome: a database of reactions, pathways and biological processes","volume":"39","author":"D Croft","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nbt.2017","article-title":"Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity","volume":"29","author":"T Anastassiadis","year":"2011","journal-title":"Nat Biotechnol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-4614-0980-9_9","article-title":"Influenza virus entry","volume":"726","author":"M Luo","year":"2012","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1083\/jcb.91.3.601","article-title":"Infectious entry pathway of influenza virus in a canine kidney cell line","volume":"91","author":"KS Matlin","year":"1981","journal-title":"J Cell Biol"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"e1001329","DOI":"10.1371\/journal.ppat.1001329","article-title":"Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway","volume":"7","author":"E de Vries","year":"2011","journal-title":"PLoS Pathog"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tcb.2013.11.002","article-title":"EGF receptor trafficking: consequences for signaling and cancer","volume":"24","author":"A Tomas","year":"2014","journal-title":"Trends Cell Biol"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00232-014-9637-0","article-title":"Transferrin receptor-mediated endocytosis: a useful target for cancer therapy","volume":"247","author":"S Tortorella","year":"2014","journal-title":"J Membr Biol"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1128\/JVI.80.4.2013-2018.2006","article-title":"Dual wavelength imaging allows analysis of membrane fusion of influenza virus inside cells","volume":"80","author":"T Sakai","year":"2006","journal-title":"J Virol"},{"issue":"6208","key":"ref30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1257037","article-title":"Influenza A virus uses the aggresome processing machinery for host cell entry","volume":"346","author":"I Banerjee","year":"2014","journal-title":"Science"},{"issue":"1\u20132","key":"ref31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0168-1702(03)00159-X","article-title":"Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses","volume":"95","author":"JF Cros","year":"2003","journal-title":"Virus Res"},{"issue":"7","key":"ref32","doi-asserted-by":"crossref","first-page":"e11479","DOI":"10.1371\/journal.pone.0011479","article-title":"Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments","volume":"5","author":"E Bernard","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3390\/v6041801","article-title":"Hantavirus Gn and Gc envelope glycoproteins: key structural units for virus cell entry and virus assembly","volume":"6","author":"N Cifuentes-Munoz","year":"2014","journal-title":"Viruses"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0065-3527(08)60583-7","article-title":"Virus entry into animal cells","volume":"36","author":"M Marsh","year":"1989","journal-title":"Adv Virus Res"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1128\/JVI.79.11.6655-6663.2005","article-title":"Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1","volume":"79","author":"RS Milne","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virol.2005.09.037","article-title":"Poxvirus entry and membrane fusion","volume":"344","author":"B Moss","year":"2006","journal-title":"Virology"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1128\/JVI.76.3.1391-1399.2002","article-title":"Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture","volume":"76","author":"M Takeda","year":"2002","journal-title":"J Virol"},{"issue":"Pt 7","key":"ref38","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1099\/vir.0.020370-0","article-title":"High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state","volume":"91","author":"C Seitz","year":"2010","journal-title":"J Gen Virol"},{"issue":"1\u20133","key":"ref39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-5793(04)00108-5","article-title":"MEK inhibition impairs influenza B virus propagation without emergence of resistant variants","volume":"561","author":"S Ludwig","year":"2004","journal-title":"FEBS Lett"},{"issue":"7","key":"ref40","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1462-5822.2007.00902.x","article-title":"Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity","volume":"9","author":"I Mazur","year":"2007","journal-title":"Cell Microbiol"},{"issue":"17","key":"ref41","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1128\/JVI.01774-14","article-title":"Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo","volume":"88","author":"O Perwitasari","year":"2014","journal-title":"J Virol"},{"issue":"17","key":"ref42","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1128\/JVI.00583-15","article-title":"Targeting Importin-alpha7 as a Therapeutic Approach against Pandemic Influenza Viruses","volume":"89","author":"P Resa-Infante","year":"2015","journal-title":"J Virol"},{"issue":"9","key":"ref43","doi-asserted-by":"crossref","first-page":"e1001099","DOI":"10.1371\/journal.ppat.1001099","article-title":"The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells","volume":"6","author":"T Eierhoff","year":"2010","journal-title":"PLoS Pathog"},{"issue":"32","key":"ref44","doi-asserted-by":"crossref","first-page":"24676","DOI":"10.1074\/jbc.M110.106278","article-title":"PKA regulates vacuolar H+-ATPase localization and activity via direct phosphorylation of the a subunit in kidney cells","volume":"285","author":"R Alzamora","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.febslet.2006.01.018","article-title":"A WNK kinase binds and phosphorylates V-ATPase subunit C","volume":"580","author":"A Hong-Hermesdorf","year":"2006","journal-title":"FEBS Lett"},{"issue":"22","key":"ref46","doi-asserted-by":"crossref","first-page":"13029","DOI":"10.1128\/JVI.01430-14","article-title":"Stepwise priming by acidic pH and a high K+ concentration is required for efficient uncoating of influenza A virus cores after penetration","volume":"88","author":"S Stauffer","year":"2014","journal-title":"J Virol"},{"issue":"7","key":"ref47","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.bpj.2014.02.018","article-title":"pH-Controlled two-step uncoating of influenza virus","volume":"106","author":"S Li","year":"2014","journal-title":"Biophys J"},{"key":"ref48","article-title":"Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication","author":"O Perwitasari","year":"2015","journal-title":"Assay Drug Dev Technol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3389\/fmicb.2015.00676","article-title":"Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection","volume":"6","author":"A Benedict","year":"2015","journal-title":"Front Microbiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2015.03.012","article-title":"The kinase-inhibitor sorafenib inhibits multiple steps of the Hepatitis C Virus infectious cycle in vitro","volume":"118","author":"V Descamps","year":"2015","journal-title":"Antiviral Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.antiviral.2014.03.009","article-title":"The multi-targeted kinase inhibitor sorafenib inhibits enterovirus 71 replication by regulating IRES-dependent translation of viral proteins","volume":"106","author":"M Gao","year":"2014","journal-title":"Antiviral Res"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00018-010-0510-8","article-title":"The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication","volume":"68","author":"M Michaelis","year":"2011","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"ref53","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1309\/AJCP7JYHJN1PGQVC","article-title":"Viral drug sensitivity testing using quantitative PCR: effect of tyrosine kinase inhibitors on polyomavirus BK replication","volume":"134","author":"PS Randhawa","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"ref54","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1002\/jcp.25014","article-title":"GRP78\/Dna K Is a Target for Nexavar\/Stivarga\/Votrient in the Treatment of Human Malignancies, Viral Infections and Bacterial Diseases","volume":"230","author":"JL Roberts","year":"2015","journal-title":"J Cell Physiol"},{"issue":"21","key":"ref55","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00968-17","article-title":"Sorafenib Impedes Rift Valley Fever Virus Egress by Inhibiting Valosin-Containing Protein Function in the Cellular Secretory Pathway","volume":"91","author":"A Brahms","year":"2017","journal-title":"J Virol"},{"issue":"5","key":"ref56","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1177\/0300985810378651","article-title":"Comparative pathology of select agent influenza a virus infections","volume":"47","author":"T Kuiken","year":"2010","journal-title":"Vet Pathol"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jac\/dkq387","article-title":"Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181","volume":"66","author":"GB Triana-Baltzer","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coviro.2014.04.009","article-title":"The epidemiology and spread of drug resistant human influenza viruses","volume":"8","author":"AC Hurt","year":"2014","journal-title":"Curr Opin Virol"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.antiviral.2005.07.004","article-title":"Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice","volume":"68","author":"O Ferraris","year":"2005","journal-title":"Antiviral Res"},{"issue":"7","key":"ref60","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.bjc.6604965","article-title":"Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes","volume":"100","author":"C Alfaro","year":"2009","journal-title":"Br J Cancer"},{"issue":"12","key":"ref61","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1182\/blood-2007-02-075945","article-title":"Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses","volume":"111","author":"MM Hipp","year":"2008","journal-title":"Blood"},{"issue":"12","key":"ref62","doi-asserted-by":"crossref","first-page":"8286","DOI":"10.4049\/jimmunol.0902404","article-title":"The kinase inhibitors sunitinib and sorafenib differentially affect NK cell antitumor reactivity in vitro","volume":"183","author":"M Krusch","year":"2009","journal-title":"J Immunol"},{"issue":"6","key":"ref63","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/leu.2008.58","article-title":"Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation","volume":"22","author":"W Zhao","year":"2008","journal-title":"Leukemia"},{"issue":"1","key":"ref64","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/cei.13128","article-title":"Sorafenib paradoxically activates the RAS\/RAF\/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose- and time-dependent manner","volume":"193","author":"J Lohmeyer","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.intimp.2017.02.028","article-title":"Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo","volume":"46","author":"MM Sunay","year":"2017","journal-title":"Int Immunopharmacol"},{"issue":"13","key":"ref66","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1158\/1078-0432.CCR-11-0253","article-title":"Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination","volume":"17","author":"SF Mulder","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"4","key":"ref67","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Y Furuta","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"ref68","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1158\/1078-0432.CCR-11-1900","article-title":"A phase I dose-escalation study of regorafenib (BAY 73\u20134506), an inhibitor of oncogenic, angiogenic, and stromal kinases, in patients with advanced solid tumors","volume":"18","author":"K Mross","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"15","key":"ref69","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.1158\/1078-0432.CCR-04-2658","article-title":"Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43\u20139006, in patients with advanced, refractory solid tumors","volume":"11","author":"JW Clark","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"3","key":"ref70","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1046\/j.1365-2141.1996.00384.x","article-title":"PMA-induced megakaryocytic differentiation of HEL cells is accompanied by striking modifications of protein kinase C catalytic activity and isoform composition at the nuclear level","volume":"92","author":"G Zauli","year":"1996","journal-title":"Br J Haematol"},{"issue":"8","key":"ref71","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"NE Sanjana","year":"2014","journal-title":"Nat Methods"},{"issue":"Pt 8","key":"ref72","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1099\/vir.0.031203-0","article-title":"Lack of transmission of a human influenza virus with avian receptor specificity between ferrets is not due to decreased virus shedding but rather a lower infectivity in vivo","volume":"92","author":"KL Roberts","year":"2011","journal-title":"J Gen Virol"},{"issue":"Pt 2","key":"ref73","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1099\/vir.0.006122-0","article-title":"Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in mice","volume":"90","author":"N Wressnigg","year":"2009","journal-title":"J Gen Virol"},{"issue":"11","key":"ref74","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"E Hoffmann","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref75","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1128\/JVI.01899-07","article-title":"Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants","volume":"82","author":"T Watanabe","year":"2008","journal-title":"J Virol"},{"issue":"22","key":"ref76","doi-asserted-by":"crossref","first-page":"13269","DOI":"10.1128\/JVI.01636-14","article-title":"Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom","volume":"88","author":"RA Elderfield","year":"2014","journal-title":"J Virol"},{"issue":"5","key":"ref77","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1073\/pnas.0437841100","article-title":"RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription","volume":"100","author":"Q Ge","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ref78","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/gb-2006-7-7-r66","article-title":"Analysis of cell-based RNAi screens","volume":"7","author":"M Boutros","year":"2006","journal-title":"Genome Biol"},{"issue":"14","key":"ref79","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/bioinformatics\/btg232","article-title":"CLICK and EXPANDER: a system for clustering and visualizing gene expression data","volume":"19","author":"R Sharan","year":"2003","journal-title":"Bioinformatics"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1471-2105-6-232","article-title":"EXPANDER\u2014an integrative program suite for microarray data analysis","volume":"6","author":"R Shamir","year":"2005","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"ref81","article-title":"Bioassay Analysis using R","volume":"12","author":"CS Ritz","year":"2005","journal-title":"J Statist Software"},{"issue":"4","key":"ref82","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1462-5822.2006.00841.x","article-title":"IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein","volume":"9","author":"B Opitz","year":"2007","journal-title":"Cell Microbiol"},{"issue":"4","key":"ref83","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"issue":"6","key":"ref84","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cbic.201000776","article-title":"Inhibition of influenza virus activity by multivalent glycoarchitectures with matched sizes","volume":"12","author":"I Papp","year":"2011","journal-title":"Chembiochem"},{"issue":"10","key":"ref85","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nri2851","article-title":"Central roles of NLRs and inflammasomes in viral infection","volume":"10","author":"TD Kanneganti","year":"2010","journal-title":"Nat Rev Immunol"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1007601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T21:10:23Z","timestamp":1588972223000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1007601"}},"subtitle":[],"editor":[{"given":"Ana","family":"Fernandez-Sesma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":85,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1007601","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]}}}